RESUMEN
Heart failure is characterized by the inability of the cardiovascular system to maintain oxygen (O2) delivery (i.e., muscle blood flow in non-hypoxemic patients) to meet O2 demands. The resulting increase in fractional O2 extraction can be non-invasively tracked by deoxygenated hemoglobin concentration (deoxi-Hb) as measured by near-infrared spectroscopy (NIRS). We aimed to establish a simplified approach to extract deoxi-Hb-based indices of impaired muscle O2 delivery during rapidly-incrementing exercise in heart failure. We continuously probed the right vastus lateralis muscle with continuous-wave NIRS during a ramp-incremental cardiopulmonary exercise test in 10 patients (left ventricular ejection fraction <35%) and 10 age-matched healthy males. Deoxi-Hb is reported as % of total response (onset to peak exercise) in relation to work rate. Patients showed lower maximum exercise capacity and O2 uptake-work rate than controls (P<0.05). The deoxi-Hb response profile as a function of work rate was S-shaped in all subjects, i.e., it presented three distinct phases. Increased muscle deoxygenation in patients compared to controls was demonstrated by: i) a steeper mid-exercise deoxi-Hb-work rate slope (2.2±1.3 vs 1.0±0.3% peak/W, respectively; P<0.05), and ii) late-exercise increase in deoxi-Hb, which contrasted with stable or decreasing deoxi-Hb in all controls. Steeper deoxi-Hb-work rate slope was associated with lower peak work rate in patients (r=-0.73; P=0.01). This simplified approach to deoxi-Hb interpretation might prove useful in clinical settings to quantify impairments in O2 delivery by NIRS during ramp-incremental exercise in individual heart failure patients.
Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Consumo de Oxígeno/fisiología , Hemoglobinas/análisis , Músculo Esquelético/metabolismo , Insuficiencia Cardíaca/fisiopatología , Pierna/irrigación sanguínea , Estudios de Casos y Controles , Estudios Prospectivos , Músculo Esquelético/fisiopatología , Espectroscopía Infrarroja Corta , Prueba de Esfuerzo , Insuficiencia Cardíaca/metabolismo , Pierna/fisiopatologíaRESUMEN
Heart transplantation is associated with rapid bone loss and an increased prevalence and incidence of fractures. The aim of the present study was to compare the bone mineral density (BMD) of 30 heart transplant (HT) recipients to that of 31 chronic heart failure (CHF) patients waiting for transplantation and to determine their biochemical markers of bone resorption and hormone levels. The BMD of lumbar spine and proximal femur was determined by dual-energy X-ray absorptiometry. Anteroposterior and lateral radiographs of the thoracic and lumbar spine were also obtained. The mean age of the two groups did not differ significantly. Mean time of transplantation was 25.4 + ou - 21.1 months (6 to 88 months). Except for the albumin levels, which were significantly higher, and magnesium levels, which were significantly lower in HT patients when compared to CHF patients, all other biochemical parameters and hormone levels were within the normal range and similar in the two groups. Both groups had lower BMD of the spine and proximal femur compared to young healthy adults. However, the mean BMD of HT patients was significantly lower than in CHF patients at all sites studied. Bone mass did not correlate with time after transplantation or cumulative dose of cyclosporine A. There was a negative correlation between BMD and the cumulative dose of prednisone. These data suggest that bone loss occurs in HT patients mainly due to the use of corticosteroids and that in 30 per cent of the patients it can be present before transplantation. It seems that cyclosporine A may also play a role in this loss.
Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Densidad Ósea , Trasplante de Corazón , Corticoesteroides/efectos adversos , Densidad Ósea/efectos de los fármacos , Cardiomiopatía Chagásica/cirugía , Insuficiencia Cardíaca/cirugía , Isquemia Miocárdica/cirugía , Osteoporosis , Periodo PosoperatorioRESUMEN
The purpose of the present study was to investigate the expression (mRNA) of CD40 ligand (CD40L), interferon-gamma (IFN-gamma) and Fas ligand (FasL) genes in human cardiac allografts in relation to the occurrence of acute cardiac allograft rejection as well as its possible value in predicting acute rejection. The mRNA levels were determined by a semiquantitative reverse transcriptase-polymerase chain reaction method in 39 samples of endomyocardial biopsies obtained from 10 adult cardiac transplant recipients within the first six months after transplantation. Biopsies with ongoing acute rejection showed significantly higher CD40L, IFN-gamma and FasL mRNA expression than biopsies without rejection. The median values of mRNA expression in biopsies with and without rejection were 0.116 and zero for CD40L (P<0.003), 0.080 and zero for IFN-gamma (P<0.0009), and 0.156 and zero for FasL (P<0.002), respectively. In addition, the levels of IFN-gamma mRNA were significantly increased 7 to 15 days before the appearance of histological evidence of rejection (median of 0.086 in pre-rejection biopsies), i.e., they presented a predictive value. This study provides further evidence of heightened expression of immune activation genes during rejection and shows that some of these markers may present predictive value for the occurrence of acute rejection.
Asunto(s)
Humanos , Adulto , Endocardio/metabolismo , Rechazo de Injerto/inmunología , Trasplante de Corazón/inmunología , Miocardio/metabolismo , Proteínas/metabolismo , ARN Mensajero/análisis , Biopsia , Ligando de CD40/genética , Ligando de CD40/metabolismo , Endocardio/patología , Expresión Génica , Interferón gamma/genética , Interferón gamma/metabolismo , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/metabolismo , Miocardio/patología , Valor Predictivo de las Pruebas , Proteínas/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Trasplante HomólogoRESUMEN
Uma das grandes barreiras a serem vencidas em vários programas de transplantes é o diagnóstico e controle da rejeiçäo. Apesar de todo progresso nesse campo, a biópsia endomiocárdica continua sendo ainda a técnica mais objetiva e confiável para detecçäo e monitorizaçäo de rejeiçäo no transplante cardíaco. Por tratar-se de método invasivo com alguns inconvenientes, continuam a ser pesquisadas técnicas alternativas menos agressivas que possam dar diagnóstico precoce. Os autores fazem uma revisäo sobres aspectos clínicos, radiológicos, eletrocardiográficos e ecocardiográficos, além de mapeamento com radionuclídeos, ressonância nuclear magnética, testes bioquímicos na urina e monitorizaçäo cito-imunológica do sangue periférico. Cumpre lembrar que após o advento da ciclosporina A, tornou-se mais difícil a detecçäo da rejeiçäo precoce e esses métodos näo-invasivos, apesar de ajudarem, perderam relvância, tendo ainda a biópsia papel fundamental.
Asunto(s)
Rechazo de Injerto , Trasplante de Corazón , Biopsia , DiagnósticoRESUMEN
As dissecçöes agudas da aorta representam uma entidade clínica não rara e de extrema gravidade. O diagnóstico precoce pode ser realizado e, para tanto, é necessário alto grau de suspeita clínica, que irá direcionar os exames a serem realizados com presteza, levando sempre em consideração a experiência da instituição com diversos exames complementares. Recomenda-se a utilização do método diagnóstico de maior acurácia e que proporcione menor estresse ao paciente. Assim que for levantada suspeita clínica de dissecção da aorta, deve ser instituída terapêutica clínica. Com a confirmação diagnóstica de diassecção envolvendo a aorta ascendente, é mandatório o tratamento cirúrgico imediato. Nos casos de dissecção da aorta descendente, o tratamento clínico é o de escolha, a menos que haja indícios de complicaçöes decorrentes da dissecção, Recentemente, novas perspectivas terapêuticas têm sido desenvolvidas e testadas com resultados bastante promissores, entre as quais destacam-se a técnica cirúrgica a tromba de elefante e o tratamento com prótese endovascular ("stent"), pela via percutânea, para correçäo das dissecçöes da aorta descendente.